
ASPEN PHAR.UN.ADR /1 Depository Receipt · US04530Y1064 · A2PWTE (XFRA) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ASPEN PHAR.UN.ADR /1
No Price
01.05.2026 13:57
Current Prices from ASPEN PHAR.UN.ADR /1
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
APNHY
|
USD
|
01.05.2026 13:57
|
8,04 USD
| -0,36 USD
-4,29 %
|
Düsseldorf |
APHPLC64.DUSB
|
EUR
|
30.04.2026 17:30
|
6,90 EUR
| - |
Quotrix |
APHPLC64.DUSD
|
EUR
|
30.04.2026 05:27
|
7,30 EUR
| - |
Company Profile for ASPEN PHAR.UN.ADR /1 Depository Receipt
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Company Data
Name ASPEN PHAR.UN.ADR /1
Company Aspen Pharmacare Holdings Limited
Website
https://www.aspenpharma.com
Primary Exchange
Frankfurt
Frankfurt
WKN A2PWTE
ISIN US04530Y1064
Asset Class Depository Receipt
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Stephen Bradley Saad BCom,
Market Capitalization 4 Mrd.
Country South Africa
Currency EUR
Employees 8,9 T
Address Aspen Place, Durban
IPO Date 2010-04-05
Dividends from 'ASPEN PHAR.UN.ADR /1'
| Ex-Date | Dividend per Share |
|---|---|
| 03.10.2025 | 0,12 USD |
| 20.09.2024 | 0,21 USD |
| 21.09.2023 | 0,18 USD |
| 22.09.2022 | 0,18 USD |
| 22.09.2021 | 0,18 USD |
| 04.10.2018 | 0,15 USD |
| 05.10.2017 | 0,15 USD |
| 12.10.2016 | 0,17 USD |
| 05.10.2016 | 0,13 USD |
| 07.10.2015 | 0,14 USD |
Stock Splits
| Date | Split |
|---|---|
| 02.11.2012 | 5:1 |
| 18.07.2012 | 5:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | APNHY |
| Düsseldorf | APHPLC64.DUSB |
| Frankfurt | LDZU.F |
| Quotrix | APHPLC64.DUSD |
More Shares
Investors who hold ASPEN PHAR.UN.ADR /1 also have the following shares in their portfolio:
